June 6, 2023

ACR DSI hosted a free webinar with more than 200 participants on May 31 that focused on the impacts of non-interpretive AI in radiology, the importance of exploring non-interpretive AI use cases, and outlook and potential advancements with non-interpretive AI.   

The webinar featured keynote speaker Woojin Kim, MD, Chief Medical Information Officer at Rad AI, who discussed enhancing the imaging value chain, improving efficiency and productivity, supporting administrative and operational use cases, and advancements in Natural Language Processing and Generative AI.    

Following the keynote presentation, there was a Q&A panel with expert panelists:  

  • Nina Kottler, MD, MS, Chief Medical Officer for Clinical AI at Radiology Partners 
  • Andrea Borondy Kitts, MS, MPH, Lung Cancer and Patient Advocate and Chief Operating Officer at Prosumer Health 
  • Howard (Po-Hao) Chen, MD, MBA, Chief Imaging Informatics Officer and IT Medical Director for Enterprise Radiology, and Staff Radiologist in Musculoskeletal Imaging at Cleveland Clinic 
  • Marta Heilbrun, MD, MS, Associate Medical Director, Imaging Services: Quality and Patient Safety at Intermountain Healthcare 

Watch our webinar on demand here.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more